{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:51:34Z","timestamp":1793314294070,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013779","name":"Retina Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"NEI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.exer.2023.109666","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T10:45:17Z","timestamp":1696416317000},"page":"109666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Artesunate mitigates choroidal neovascularization and scar formation"],"prefix":"10.1016","volume":"236","author":[{"given":"Nader","family":"Sheibani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Seok","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Farnoodian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samay","family":"Inampudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoujian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soesiawati R.","family":"Darjatmoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Sorenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2023.109666_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000076256","article-title":"Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR\/flk-1","volume":"71","author":"Chen","year":"2004","journal-title":"Pharmacology"},{"key":"10.1016\/j.exer.2023.109666_bib2","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1167\/iovs.12-11068","article-title":"The artemisinin derivative artesunate inhibits corneal neovascularization by inducing ROS-dependent apoptosis in vascular endothelial cells","volume":"54","author":"Cheng","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2023.109666_bib3","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.bcp.2004.08.021","article-title":"Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate","volume":"68","author":"Dell'Eva","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exer.2023.109666_bib4","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1371\/journal.pone.0000693","article-title":"Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells","volume":"2","author":"Efferth","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2023.109666_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232779","article-title":"Bim expression modulates the pro-inflammatory phenotype of retinal astroglial cells","volume":"15","author":"Falero-Perez","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2023.109666_bib6","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12266","article-title":"Expression of pigment epithelium-derived factor and thrombospondin-1 regulate proliferation and migration of retinal pigment epithelial cells","volume":"3","author":"Farnoodian","year":"2015","journal-title":"Physiological reports"},{"key":"10.1016\/j.exer.2023.109666_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116423","article-title":"Expression of thrombospondin-1 modulates the angioinflammatory phenotype of choroidal endothelial cells","volume":"9","author":"Fei","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2023.109666_bib8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ophtha.2013.08.015","article-title":"Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Grunwald","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2023.109666_bib9","doi-asserted-by":"crossref","first-page":"L607","DOI":"10.1152\/ajplung.00390.2009","article-title":"Opposing effects of bim and bcl-2 on lung endothelial cell migration","volume":"299","author":"Grutzmacher","year":"2010","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.exer.2023.109666_bib10","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2023.109666_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.exer.2023.109666_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/jop.2018.0097","article-title":"A pilot clinical study of intravitreal injection of artesunate for ocular neovascularization","volume":"35","author":"Li","year":"2019","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.exer.2023.109666_bib13","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201867R","article-title":"Artesunate protects against ocular fibrosis by suppressing fibroblast activation and inducing mitochondria-dependent ferroptosis","volume":"37","author":"Liu","year":"2023","journal-title":"Faseb. J."},{"key":"10.1016\/j.exer.2023.109666_bib14","first-page":"7055","article-title":"In vitro oxygen availability modulates the effect of artesunate on HeLa cells","volume":"34","author":"Murray","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.exer.2023.109666_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/c6b85ec4-996d-4daf-863a-44260a888470","article-title":"Choroid sprouting assay: an ex vivo model of microvascular angiogenesis","volume":"8","author":"Shao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2023.109666_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111234","article-title":"Artesunate: a natural product-based immunomodulator involved in human complement","volume":"136","author":"Song","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exer.2023.109666_bib17","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41419-019-2084-1","article-title":"Artesunate induces mitochondria-mediated apoptosis of human retinoblastoma cells by upregulating Kruppel-like factor 6","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.exer.2023.109666_bib18","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/IAE.0000000000000081","article-title":"Exacerbation of choroidal and retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration","volume":"34","author":"Young","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.exer.2023.109666_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.vph.2007.05.002","article-title":"Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells","volume":"47","author":"Zhou","year":"2007","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.exer.2023.109666_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/srep30843","article-title":"Small molecular-sized artesunate attenuates ocular neovascularization via VEGFR2, PKCalpha, and PDGFR targets","volume":"6","author":"Zong","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483523002877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483523002877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:36:13Z","timestamp":1751402173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483523002877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":20,"alternative-id":["S0014483523002877"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2023.109666","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate mitigates choroidal neovascularization and scar formation","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2023.109666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109666"}}